CANCER REGISTRY 2002

Transcription

1

2 2

3 National Cancer Institute Department of Medical Services Ministry of Public Health Thailand Edited by Pattarawin Attasara, M.D. ISSN

4 NATIONAL INSTITUTE STAFFS Consultant : Editor : Office Staffs : Asst. Prof. Visoot Vootiprux Pattarawin Attasara, M.D. Mrs. Rangsiya Buasom Mrs. Prathum Prakobpan Mrs. Phikul Panchaem Mr. Somchoke Hongtong Ms. Pannaporn Kusol Ms. Penpak Hongjet Ms. Maliwan Saroj

5 A INTRODUCTION This annual report of new cancer registered in The National Cancer Institute is the hospital base report. The Topographic and The Morphologic code of cancer are based on The International Classificaiton of Disease for Oncology, Third Edition. It is hope that the data many be useful for those who are interest in oncology and those faculty member who are planning for human resource, personal development and research on oncology. This report has been made possible by the collaboration of all departments in the hospital. Thanks to all faculty members for their collaboration and also for all registry staffs, consultant, and volunteer in the record department for their diligence and untiring enthusiasm in the performance of their duties in processing the data upon which this volume is based on. Thiravud Khuhaprema, M.D., F.I.C.S. Director, National Cancer Institute, Bangkok, Thailand

6 6

7 C Introduction A Table 1 Number of Patients 1 Table 2 The Most Common Cancers : Males 1 Table 3 The Most Common Cancers : Females 2 Table 4 Type of Diagnosis of Cancer Site of All Cancer 2 Table 5 Type of Extension of Cancer of All Cancer 4 Table 6 Number by Age-Group and Sex for All Cancer 6 Table 7 Method of Cancer Site of All Cancer 8 Table 8 Method of Treatment in Cancer of All Cancer 10 CONTENTS Table 9 Number of Cases by Age - Group in Males 11 Table 10 Number of Cases by Age - Group in Females 12 Table 11 Pathology According to Sites Table 12 Number of Patients Breast Cancer 21 Table 13 Type of Diagnosis of Breast 21 Table 14 Type of Extension of Cancer breast 21 Table 15 Number by Age - Group of Sex for breast 22 Table 16 Treatment of Cancer Site of Breast 22 Table 17 Method of Treatment in Cancer of Breast 23 Table 18 Number of Patients Cervix Cancer 24 Table 19 Type of Diagnosis Cervix Cancer 24 Table 20 Type of Extension of Cancer of Cervix 24 Table 21 Number By Age - Group and Sex For Cervix 25 Table 22 Method of Cancer Site of Cervix 25 Table 23 Method of Treatment in Cancer of Cervix 26 Table 24 Number of Patient Lung Cancer 27

8 D Table 25 Type of Diagnosis of Cancer Site of Lung 27 Table 26 Type of Extension of Cancer of Lung 27 Table 27 Number by Age - Group and Sex for Lung 28 Table 28 Treatment of Cancer Site of Lung 28 Table 29 Method of Treatment in Cancer of Lung 29 Table 30 Number of Patients Rectum Cancer 30 Table 31 Type of Diagnosis in Cancer Site of Rectum 30 Table 32 Type of Extension in Cancer of Rectum 30 Table 33 Number Age - Group and Sex for Rectum 31 CONTENTS Table 34 Method of Cancer Site of Rectum 31 Table 35 Method of Treatment in Cancer of Rectum 32 Table 36 Number of Patients Oral Cavity Cancer 33 Table 37 Type of Diagnosis of Cancer Site of Oral Cavity 33 Table 38 Type of Extension of Cancer of Oral Cavity 33 Table 39 Number by Age - Group and Sex for Oral Cavity 34 Table 40 Method of Cancer Site of Oral Cavity 34 Table 41 Method of Treatment in Cancer of Oral Cavity 35 Figure 1 Type of Diagnosis of Cancer Site of All Cancer 3 Figure 2 Type of Extension of Cancer of All Cancer 5 Figure 3 Number by Age - Group and Sex for All Cancer 7 Figure 4 Treatment of Cancer Site of All Cancer 9 Figure 5 Ditribution of Cancer Patients by Region 36

9 9 TABLE 1 Number of Patients Type of Patient No. of Case Percent Total number of new patients 34, Total number of new patients with malignancies 3, TABLE 2 The Most Common Cancers : Males No. Site ICD 0 No. of Case 1 Traches, Bronchus & Lung C33 - C Liver and Intrahepatic bile ducts C Rectum, Rectosignoid and Anus C19 - C Colon C Nasopharynx C Esophagus C Tongue C01 - C Skin C43 - C Mouth C03 - C Lumph nodes C77 34

10 10 TABLE 3 The Most Common Cancers : Females No. Site ICD 0 No. of Cases 1 Breast C Cervix C Trachea, Bronchus & Lung C33 -C Thyroid gland C Ovary C Corpus uteri C Liver and Intrahepatic bile ducts C Rectum, Rectosigmoid and Anus C19 - C Colon C Lumph nodes C78 50 TABLE 4 Type of Diagnosis of Cancer Site of All Cancer Type of Diagnosis Death Certificate only History & Physical exam Endoscopy & Radiology Surgery & Autopsy (no histol) Specific Biochem/Immuno tests Cytology or Hematology Histology of Metastatic Histology of Primary , , Autopsy with Histology Unknown All Patients 1, , ,

11 History of Primary Endoscopy & Radiology FIGURE 1 Type of Diagnosis of Cancer Site of All Cancer History of Metastatic History & Physical exam Cytology or Hematology Specific Biochem/Immuno tests MALE % FEMALE % %

12 12 TABLE 5 The Type of Extension of Cancer of All Cancer Type of Extension Not record In situ Localized Direct extension , Regional lymph nodes Distant metastasis Not applicable Not known All Patients 1, , ,

13 13 MALE % FEMALE % FIGURE 2 Type of Extension of Cancer Site of All Cancer Localized Direct extension Regional lymph nodes Direct metastasis Not applicable Not known

14 14 TABLE 6 Number by Age - Group and Sex for All Cancer Age Not record > All Patients 1, , ,

15 15 >= FIGURE 3 Number by Age - Group and Sex for All Cancer >0-04 Not record MALE % FEMALE %

16 16 TABLE 7 Method of Cancer Site of All Cancer Method Surgery , , Radiatherapy , Chemotherapy , Hormone Immuno Supportive Other All Treatment 1, , ,

17 17 Chemotherapy 29% Immuno 0% Hormone 0% Other 3% FIGURE 4 Treatment of Cancer Site of All Cancer Supportive 6% Radiation 27% Surgery 35% Surgery Radiation Chemotherapy Hormone Immuno Other Supportive

18 18 TABLE 8 Method of Treatment in Cancer Method Surgery only Radiatherapy only Chemotherapy only Hormone only Suportive only Surgery + Radiatherapy Surgery + Radiatherapy + Chemotherapy Surgery + Chemotherapy Surgery + Chemotherapy + Hormone Surgery + Immunotherapy Radiatherapy + Chemotherapy Chemotherapy + Hormone Other Not record All Patients 1, , ,

19 19 TABLE 9 Number of Cases by Age - Group in Males All Age Site ICD Age UNK. Lip C Tongue C Mouth C03-C Salivary gland C07-C Oropharyux C09-C Nasopharynx C Hypopharynx C12-C Orl Cavity C14 0 Esophagus C Stomach C Small intestine C Colon C Rectum, Rectosignoid and Anus C19-C Liver and Intrahepatic bile ducts C Gallbladder and other parts of biliary tract C23-C Pancreas C Other and ill-defined digestive organs C Nasal Cavities, Sinuses & Ear C30-C Larynx C Traches, Bronchus & Lung C33-C Thymus Mediastinum C37-C Bone C40-C Hematopoietic and Reticuoendothelial C Skin C43-C Connective, Subcu & Soft Tissues C47, C Retroperioneum and peritoneum C Breast C Other unspecified female genital organs C51-C52,C37 0 Cervix C53 0 Corpus uteri C54 0 Utenus C55 0 Ovary C56 0 Placenta C58 0 Penis C Prostate Gland C Testis C Other and unspecified male genital organs C Kidney and other urinary organs C64-C66,C Urinary bladder C Eye and adnexa C Brain and nervous system C70-C Thyroid gland C Other endocrine glands C74-C Other and ill-defined sites C76 0 Lymph nodes C Unknown primary site C All Sites 1,

20 20 TABLE 10 Number of Cases by Age - Group in Females All Age Site ICD Age UNK. Lip C Tongue C Mouth C03-C Salivary gland C07-C Oropharynx C09-C Nasopharynx C Hypoharynx C12-C Oral Cavity C14 0 Esophagus C Stomach C Small intestine C Colon C Rectum, Rectosigmoid and Anus C19-C Liver and Intrahepatic bile ducts C Gallbladder and other parts of biliary tract C23-C Pancreas C Other and ill-defined digestive organs C Nasal Cavities, Sinuses & Ear C30-C Larynx C Trachea, Bronchus & Lung C33-C Heart, mediastium, and Pleura C37-C Other and Defined sites intrathoracic C39 0 Bone, Joint & Articular Cartilage C40-C Hematopoietic and Reticuoendothelial C Skin C43-C Connective, Subcu & Soft Tissues C47-C Retroperitoneum and peritoneum C Breast C Other unspecified female genital organs C51-C52,C Cervix C Corpus uteri C Uterus C55 0 Ovary C Placenta C58 0 Penis C60 0 Prostate Gland C61 0 Testis C62 0 Other and unspecified male gential organs C63 0 Kidney and other urinary organs C64-C66,C Urinary bladder C67 0 Eye and adnexa C Brain and nervous system C70-C Thyroid gland C Other endocrine glands C74-C Other and ill-defined sites C76 0 Lymph nodes C Unknown prinary site C All Sites 2,

21 21 TABLE 11 Pathology According to Sites Pathology and Sites M F Total C00 Lip Verrucous carcinoma Squamous cell carcinoma Adenoid cystics carcinoma Neoplasm, malignant C01 - C02 Tongue Squamous cell carcinoma Non-Hodgkin lymphoma Neoplasm, malignant C03 - C06 Mouth Verrucous carcinoma Squamous cell carcinoma Adenocarcinoma Adenoidcystic carcinoma Mucoepidermoid carcinoma C07 - C08 Salivary glands Carcinoma, undifferentiate Carcinoma, anaplastic Adenocarcinoma Adenoidcystic carcinoma Acinar cell carcinoma Mucoepidermoid carcinoma Epithelial-myoepithelial carcinoma C09 - C10 Oropharynx Squamous cell carcinoma Carcinoma, undifferentiate Malignant lymphoma Malignant lymphoma large cell Non-Hodkin lymphoma Neoplasm, malignant C11 Nasopharynx Squamous cell carcinoma Carcinoma, undifferentiate Carcinoma Malignant tumour, small cell type Neoplasm, malignant Squamous cell carcinoma keratingizing Squamous cell carcinoma, large cell non keratingizing 5 2 7

22 22 Pathology and Sites M F Total C12 - C13 Hypopharynx Squamous cell carcinoma Carcinoma, undifferentiate Non-Hodgkin lymphoma Neoplasm, malignant C15 Oesophagus Squamous cell carcinoma Adenocarcinoma Carcinoma, undifferentiate Neoplasm, malignant C16 Stomach Adenocarcinoma Carcinoma, undifferentiate Signet ring cell adenocarcinoma Non-Hodgkin lymphoma Malignant lymphoma, large cell Mucin-producing adenocarcinoma Mucinous adenocarcinoma Rhabdomyosarcoma Neoplasm, malignant C17 Small Intestine Leiomyocarcoma Clear cell adenocarcinoma Malignant lymphoma, large cell C18 Colon Adenocarcinoma Mucin-producing adenocarcinoma Signet ring cell adenocarcinoma Malignant lymphoma, large cell Mucinous adenocarcinoma Malignant lymphoma, small lymphocytic Malignant lymphoma, mixed Leiomyosarcoma Tubular adenocarcinoma Neoplasm, malignant C19 - C21 Rectum, Rectosigmoid and Anus Squamous cell carcinoma Adenocarcinoma Mucin-producing adenocarcinoma Mucinous adenocarcinoma Malignant melanoma Signet ring cell adenocarcinoma Leiomyosarcoma Neoplasm, malignant

23 23 Pathology and Sites M F Total C22 Liver & Intrahepatic Bile Ducts Adenocarcinoma Cholangiocarcinoma Hepatocellular carcinoma Tumour cell, malignant Combine hepato and cholangio carcinoma Malignant lymphoma, large cell Neoplasm, malignant C23 - C24 Gallbladder & Other Parts of Biliary Tract Adenocarcinoma Carcinoma Papillary adenocarcinoma Signet ring cell adenocarcinoma Neoplasm, malignant C25 Pancreas Adenocarcinoma Neoplasm, malignant C26 Other & Ill-Define Digestive Organs Adenocarcinoma Mucin - producing adenocarcinoma C30 - C31 Nasal Cavities, Sinuses & Ear Squamous cell carcinoma Malignant tumour, small cell type Adenoid cystic carcinoma Adenocarcinoma Neuroendocine carcinoma Malignant lymphoma, mixed C32 Larynx Squamous cell carcinoma Neoplasm, malignant C33-C34 Trachea, Bronchus & Lung Tumor cell, malignant Large cell carcinoma Carcinoma, undifferentiate Small cell carcinoma Squamous cell carcinoma Adenocarcinoma Bronchiolo-alveolar adenocarcinoma Oat cell carcinoma Carcinoma Carcinoma, anaplastic Papillary adenocarcinoma 0 1 1

24 24 Pathology and Sites M F Total Alveolar adenocarcinoma Adenosquamous cell carcinoma Mucoepidemoid carcinoma Malignant lymphoma, small lymphocytic Neoplasm, malignant C37 - C38 Heart, Mediastinum and pleura Thymoma, malignant Sarcoma Mesothelioma, malignant Yolk sac tumour Teratoma, malignant Mixed germ cell tumour Malignant lymphoma, large cell Follicular lymphoma C39 Other and Defined Sites Intrathoracic Malignant tumour, small cell type C40 - C41 Bone, Joint & Articular Cartilage Spindle cell sarcoma Epitheloid sarcoma Ostiosarcoma Chondroblastic osteosarcoma Chondrosarcoma Chondroblastoma, malignant Mesenchymal chondrosarcoma Giant cell tumour of bone, malignant C42 Hematopoietic and Reticuloendothelial Systems Acute lymphobastic leukaemia Chronic myeloid leukemia Plasmacytoma Multiplemyeloma C43 - C44 Skin Squamous cell carcinoma Basal cell carcinoma Basal cell adenocarcinoma Malignant melanoma Dermatofibrosarcoma Nodular melanoma Adenoid cystic carcinoma Apocrine adenocarcinoma Sweat gland adeno carcinoma Malignant melanoma in precancerous melanosis Neoplasm, malignant Squamous cell carcinoma keratinizing Cutaneous lymphoma 0 1 1

25 25 Pathology and Sites M F Total C47; C49 Connective, Subcu. & Soft Tissues Spindle cell sarcoma Sarcoma Sylnovialsarcoma Liposarcoma Leiomyosarcoma Rhabdomyosarcoma Epitheloid sarcoma Embryonal rhabdomyosarcoma Fibrosarcoma Plomorphic rhabdomyosarcoma Malignant fibrous histeocytoma Neuroblastoma Malignant tumour, spindle cell type Hemangioendothelioma, malignant Ganglioneuroblastoma Neurilemoma, malignant Neoplasm, malignant C48 Retroperitoneum and Peritoneum Liposarcoma Endometrial stromal sarcoma C50 Breast Tumour cell, malignant Carcinoma Carcinoma, undifferentiate Papillary carcinoma Squamous cell carcinoma Adenocarcinoma Tubular adenocacinoma Papillary adenocarcinoma Apocrine adenocarcinoma Mucoid adenocarcinoma Infiltrating duct carcinoma Comedocarcinoma Intraduct papillary adenocarcinoma with invasion Medullary carcinoma Lobular carcinoma Infiltrating duct and lobular carcinoma Pleomorphic cell sarcoma Malignant fibrous histeocytoma Phylloides tumour, malignant Haemangiosarcoma Malignant lymphoma, mixed Malignant lymphoma, large cell Neoplasm, malignant

26 26 Pathology and Sites M F Total C51 - C52; C57 Other Unspecified Female Genital Organs Squmous cell carcinoma Papillary adenocarcinoma Malignant melanoma Neoplasm, malignant C53 Cervix Uteri Squamous cell carcinoma Adenocarcinoma Papillary squamous cell carcinoma Small cell carcioma Adenocarcinoma in villous adenoma Adenosquamous cell carcinoma Papillary adenocarcinoma Mucinous adenocarcinoma Spindle cell sarcoma neoplasm, malignant C54 Corpus Uteri Adenocarcinoma Endometrioid adenocarcinoma Papillary adenocarcinoma Leiomyosarcoma Clear cell adenocarcinoma Mixed cell adenocarcinoma Sarcoma Endomeetrial stromal sarcoma Non-Hodgkin lymphoma Neoplasm, malignant C56 Ovary Adenocarcinoma Clear cell adenocarcinoma Endometrioid adenocarcinoma Papillary adenocarcinoma Papillary cystadenocarcinoma Papillary serous cysadenocarcinoma Papillary mucinous cystadenocarcinoma Teratoma, malignant Neuroendocrine carcinoma Cysadenocarcinoma Serous cystadenocarcinoma Serous surface carcinoma Mucinous cystadenocarcinoma Mucinous adenocarcinoma Granulosa cell tumor, malignant Mesodermal mixed tumour Yolk sac tumour Granular cell tumor, malignant Neoplasm, malignant 0 9 9

27 27 Pathology and Sites M F Total C60 Penis Squamous cell carcinoma Carcinoma, undifferentiate C61 Prostate Gland Adenocarcinoma Neoplasm, malignant C62 Testis Seminoma Teratoma, malignant Yolk sac tumor Mixed germ cell tumor Malignant lymphoma, large cell C63 Other and Unspecified Male Genital Organs Paget disease, extramamary C64-C68 Kidney Other Urinary Organs Urinary Bladder Squamous cell carcinoma Renal cell carcinoma Transitional cell carcinoma Nephroblastoma Adenocarcinoma Neoplasm, malignant C69 Eye and Adnexa Retinoblastoma Malignant lymphoma, small lymphocyte Neoplasm, malignant C70 - C72 Brain, nervous System Germinoma Teratoma, malignant Mixed glioma Ependymoma Astrocytoma Astrocytoma, anaplastic Gemistocytic astrocytoma Pilocystic astrocytoma Glioblastoma Oligodendroglioma Oligodendroglioma anaplastic Medulloblastoma Meningioma, malignant Malignant lymphoma Malignant lymphoma, large cell Neoplasm, malignant 4 2 6

28 28 Pathology and Sites M F Total C73 Thyroid Gland Carcinoma, undifferentiate Carcinoma, anaplastic Papillary carcinoma Papillary adenocarcinoma Follicular adnocarcinoma Papillary adenocarcinoma, follicular variant Medullary carcinoma Non-Hodgkin lymphoma Neoplasm, malignant C74 - C75 Other Endocrine Glands Adrenal cortical carcinoma Neoplasm, malignant C77 Lymph Nodes Malignant lymphoma Non-Hodgkin lymphoma Hodgkin disease Hodgkin lymphoma mixed cellularity Hodgkin lymphoma nodular sclerotic Malignant lymphoma, small lymohocyte Malignant, mixed small and large cell Malignant lymphoma, large cell diffuse Malignant lymphoma, immunoblastic Malignant lymphoma, follicular Malignant lymphoma, small clear cell, nodular C80 Unknown Primary Sites Carcinoma Large cell carcinoma Carcinoma, undifferentiate Spindle cell carcinoma Squamous cell carcinoma Adenocarcinoma Schirous adenocarcinoma Adenoidcystic carcinoma Papillary adenocarcinoma Mucinproducing adenocarcinoma Signet ring cell carcinoma Malignant fibrous histiocytoma Yolk sac tumour Mixed germ cell tumour Neoplasm, malignant

29 29 TABLE 12 Number of Patients Breast Cancer Type of Patient No. of Cases Percent Total number of new patients with malignancies 3, Total number of new patients with breast cancer TABLE 13 Type of Diagnosis Breast Cancer Type of Diagnosis Death Certificate only History & Physical exam Endoscopy & Radiology Surgery & Autopsy (no histol) Specific Biochem/Immuno tests Cytology or Hematology Histology of Mestastatic Histology of Primary Autopsy with Histology Unknown All Patients TABLE 14 Type of Extension Breast Cancer Type of Extension Not record In situ Localized Direct extension Regional lymph nodes Distant metastasis Not applicable Not known All Patients

30 30 TABLE 15 Number by Age - Group and Sex for Breast Cancer Age Not record > All Patients TABLE 16 Treatment of Breast Cancer Treatment Surgery Radiatherapy Chemotherapy Hormone Immuno Supportive Other All Treatment

31 31 TABLE 17 Method of Treatment Breast Cancer Method of Treatment Surgery only Radiatherapy only Chemotherapy only Hormone only Supportive only Surgery + Radiatherapy Surgery + Radiatherapy + Chemotherapy Surgery + Chemotherapy Surgery + Chemotherapy + Hormone Surgery + Immunotherapy Radiatherapy + Chemotherapy Chemotherapy + Hormone Other Not record All Method of Treatment

32 32 TABLE 18 Number of Patients Cervix Cancer Type of Patient No. of Cases Percent Total number of new paitents with malignacies 3, Total number of new patients cervix cancer TABLE 19 Type of Diagnosis Cervix Cancer Type of Diagnosis Female Total n % n % Death Cetificate Only History & Physical exam Endoscopy & Radiology Surgery & Autopsy (no histol) Specific Biochem/Immuno tests Cytology or Hematology Histology of Mestastatic Histology of Primary Autopsy with Histology Unknow All Patients TABLE 20 Type of Extension Cervix Cancer Type of Extension Female Total n % n % Not record In situ Localized Direct extension Regional lymph nodes Distant metastasis Not applicable Not known All Patients

33 33 TABLE 21 Number by Age - Group and Sex for Cervix Cancer Age Female Total n % n % Not record > All Patients TABLE 22 Treatment of Cervix Cancer Treatment Female Total n % n % Surgery Radiatherapy Chemotherapy Hormone Immuno Supportive Other All Treatment

34 34 TABLE 23 Method of Treatment Cancer Cervix Method of Treatment Female Total n % n % Surgery only Radiatherapy only Chemotherapy only Hormone only Supportive only Surgery + Radiatherapy Surgery + Radiatherapy + Chemotherapy Surgery + Chemotherapy Surgery + Chemotherapy + Hormone Surgery + Immunotherapy Radiatherapy + Chemotherapy Chemotherapy + Hormone Other Not record Method of Treatment

35 35 TABLE 24 Number of Patient Lung Cancer Type of Patient No. of Cases Percent Total number of new patients with malignancies 3, Total number of new patients with lung cancer TABLE 25 Type of Diagnosis Lung Cancer Type of Diagnosis Death Certificate only History & Physical exam Endoscopy & Radiology Surgery & Autopsy (no histol) Specific Biochem/Immuno tests Cytology of Hematology Histology of Mestastatic Histology of Primary Autopsy with Histology Unknown All Patients TABLE 26 Type of extension Lung Cancer Type of Extension Not record In situ Localized Direct extension Regional lymph nodes Distant metastasis Not applicable Not known All Patients

36 36 TABLE 27 Number by Age - Group and Sex Lung Cancer Age Not record > All Patients TABLE 28 Treatment of Lung Cancer Treatment Surgery Radiatherapy Chemotherapy Hormone Immuno Supportive Other All Treatment

37 37 TABLE 29 Method of Treatment Lung Cancer Method of Treatment Surgery only Radiatherapy only Chemotherapy only Hormone only Supportive only Surgery + Radiatherapy Surgery + Radiatherapy + Chemotherapy Surgery + Chemotherapy Surgery + Chemotherapy + Hormone Surgery + Immunotherapy Radiatherapy + Chemotherapy Chemotherapy + Hormone Other Not record All Patients 1, , ,

38 38 TABLE 30 Number of Patients Retum cancer Type of Patient No. of Cases Percent Total number of new patients with malignancies 3, Total number of new patients with rectum cancer TABLE 31 Type of Diagnosis Rectum Cancer Type of Diagnosis Death Certificate Only History & Physical Exam Endoscopy & Radiology Surgery & Autopsy (No histol) Specific Biochem/Immuno tests Cytology or Hematology Histology of Mestastatic Histology of Primary Autopsy with Histology Unknown All Patients TABLE 32 Type of Extension Rectum Cancer Type of Extension Not record In situ Localized Direct extension Regional lymph nodes Distant metastasis Not applicable Not known All Patinets

39 39 TABLE 33 Number by Age - Group and Sex Rectum Cancer Age Not record > All Patients TABLE 34 Treatment of Rectum Cancer Treatment Surgery Radiatherapy Chemotherapy Hormone Immuno Supportive Other All Treatment ,

40 40 TABLE 35 Method of Treatment Rectum Cancer Method of Treatment Surgery only Radiatherapy only Chemotherapy only Hormone only Supportive only Surgery + Radiatherapy Surgery + Radiatherapy + Chemotherapy Surgery + Chemotherapy Surgery + Chemotherapy + Hormone Surgery + Immunotherapy Radiatherapy + Chemotherapy Chemotherapy + Hormone Other Not record All Method of Treatment

41 41 TABLE 36 Number of patients Oral Cavity Cancer Type of Patient No. of Cases Percent Total number of new patients with malignancies 3, Total number of new patients with oral cavity cancer TABLE 37 Type of Diagnosis Oral Cavity Cancer Type of Diagnosis Death Certificate only History & Physical exam Endoscopy & Radiology Surgery & Autopsy (no histol) Specific Biochem/Immuno tests Cytology or Hematology Histology of Mestastatic Histology of Primary Autopsy with Histology Unknown All Patients TABLE 38 Type of Extension Oral Cavity Cancer Type of Extension Not record In situ Localized Direct extension Regional lymph nodes Distant metastasis Not applicable Not known All Patients

42 42 TABLE 39 Number by Age - Group and Sex Oral Cavity Cancer Age Not record > All Patients TABLE 40 Treatment of Oral Cavity Cancer Treatment Surgery Radiatherapy Chemotherapy Hormone Immuno Supportive Other All Treatment

43 43 TABLE 41 Method of Treatment Oral Cavity Cancer Method of Treatment Surgery only Radiatherapy only Chemotherapy only Hormone only Supportive only Surgery + Radiatherapy Surgery + Radiatherapy + Chemotherapy Surgery + Chemotherapy Surgery + Chemotherapy + Hormone Surgery + Immunotherapy Radiatherapy + Chemotherapy Chemotherapy + Hormone Other Not record All Method of Treatment

44 44 FIGURE 5 Distribution of Cancer Patients by Region